CVR: 39432714
DKK -20,487
Gross profit
Net result: DKK -31,867
MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS
2 more
CVR · view ownership and management
Name registered: DeLiver Pharma ApS
CVR · 09/03/2018
View the full event history
DeLiver Pharma ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Niels Jonas Heilskov Graversen. The company's owners include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS. In 2025, the company reported a gross profit of DKK -20,487 and a net result of DKK -31,867 compared with DKK -21,682 the year before. Equity in the 2025 report amounted to DKK 163,221.
Selskabets formål er at drive virksomhed med medicinsk udvikling samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -32 t. | 176 t. | 163 t. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | -22 t. | 206 t. | 195 t. | 0 | |
| 202301/01/2023 – 31/12/2023 | - | 107 t. | 271 t. | 217 t. | 0 | |
| 202201/01/2022 – 31/12/2022 | - | -29 t. | 121 t. | 109 t. | - | |
| 202101/01/2021 – 31/12/2021 | - | -147 t. | 150 t. | 139 t. | - | |
| 202001/01/2020 – 31/12/2020 | - | -114 t. | 255 t. | 246 t. | - | |
| 201901/01/2019 – 31/12/2019 | 79 t. | -12 t. | 230 t. | 220 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningDeLiver Pharma ApS was founded on 9 March 2018.
DeLiver Pharma ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
The owners of DeLiver Pharma ApS include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS.
In 2025, DeLiver Pharma ApS reported a gross profit of DKK -20,487.
The management of DeLiver Pharma ApS consists of Niels Jonas Heilskov Graversen.
DeLiver Pharma ApS is located at c/o Jonas Heilskov Graversen, Sanatorievej 8, 5600 Faaborg.
Claim this page to add your logo and social links. Free to get started.
DeLiver Pharma ApS has published its annual report for 2025. Gross profit came to DKK -20,487, and the net result was DKK -31,867.
Address changed to Sanatorievej 8, 5600 Faaborg (May 29, 2026).
Contact info changed: new phone: 21733311, new email: [email protected] (May 29, 2026).
Address changed to Fuglevej 21 21, 8592 Anholt (January 7, 2026).
DeLiver Pharma ApS has published its annual report for 2024. Gross profit came to DKK -10,302, and the net result was DKK -21,682.
DeLiver Pharma ApS has published its annual report for 2023. Gross profit came to DKK 118,663, and the net result was DKK 107,283.
DeLiver Pharma ApS has published its annual report for 2022. Gross profit came to DKK -17,951, and the net result was DKK -29,331.
DeLiver Pharma ApS has published its annual report for 2021. Gross profit came to DKK -21,884, and the net result was DKK -146,911.
DeLiver Pharma ApS has published its annual report for 2020. Gross profit came to DKK -19,597, and the net result was DKK -113,852.
DeLiver Pharma ApS has published its annual report for 2019. Revenue came to DKK 79,000, and the net result was DKK -12,094.
DeLiver Pharma ApS has published its interim report for the period March 9, 2018 – December 31, 2018.
As of March 9, 2018, Jens Kristian Damsgaard has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Søren Kragh Moestrup has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Holger Jon Møller has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen is registered as director of DeLiver Pharma ApS.
As of March 9, 2018, MOESTRUP HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, MØLLER HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, PHIDEAS ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, SCIENCE VENTURES DENMARK A/S is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
DeLiver Pharma ApS was founded on March 9, 2018.
Companies in the same industry and area
